Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial Article Swipe

Jan Christoph Koch , Andreas Leha , Helen Bidner , Isabell Cordts , Johannes Dorst , René Günther , Daniel Zeller , Nathalie Braun , Moritz Metelmann , Philippe Corcia , Elisa De La Cruz , Patrick Weydt , Thomas Meyer , Julian Großkreutz , Marie‐Hélène Soriani , Shahram Attarian , Jochen H. Weishaupt , Ute Weyen , Josua Kuttler , Gabriela Zurek , Mary‐Louise Rogers , Emily Feneberg , Marcus Deschauer , Christoph Neuwirth , Joanne Wuu , Albert C. Ludolph , Jens Schmidt , Yvonne Remane , William Camu , Tim Friede , Michael Benatar , Markus Weber , Paul Lingor · YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1016/s1474-4422(24)00373-9 · OA: W4403458549